Aspen Investment Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.69M Buy
18,458
+302
+2% +$70.4K 1.26% 18
2026
Q1
$4.44M Sell
18,156
-14
-0.1% -$3.26K 1.36% 16
2025
Q4
$3.76M Buy
18,170
+8,600
+90% +$1.7M 1.13% 20
2025
Q3
$1.77M Buy
9,570
+256
+3% +$43.9K 0.69% 41
2025
Q2
$1.42M Sell
9,314
-491
-5% -$75.5K 0.6% 52
2025
Q1
$1.63M Sell
9,805
-906
-8% -$142K 0.75% 43
2024
Q4
$1.55M Sell
10,711
-1,436
-12% -$223K 0.72% 41
2024
Q3
$1.97M Sell
12,147
-42
-0.3% -$6.69K 0.92% 29
2024
Q2
$1.78M Sell
12,189
-661
-5% -$98.3K 0.89% 30
2024
Q1
$2.03M Buy
12,850
+31
+0.2% +$4.93K 1.03% 23
2023
Q4
$2.01M Sell
12,819
-3,529
-22% -$541K 1.12% 25
2023
Q3
$2.55M Buy
16,348
+188
+1% +$31K 1.54% 14
2023
Q2
$2.67M Sell
16,160
-170
-1% -$27.4K 1.59% 13
2023
Q1
$2.53M Sell
16,330
-210
-1% -$33.9K 1.62% 13
2022
Q4
$2.92M Sell
16,540
-967
-6% -$167K 1.91% 10
2022
Q3
$2.86M Sell
17,507
-44
-0.3% -$7.45K 1.91% 10
2022
Q2
$3.12M Sell
17,551
-3
-0% -$535 1.95% 10
2022
Q1
$3.11M Buy
17,554
+711
+4% +$121K 1.63% 14
2021
Q4
$2.88M Buy
16,843
+1,563
+10% +$256K 1.42% 19
2021
Q3
$2.47M Sell
15,280
-85
-0.6% -$14.5K 1.31% 22
2021
Q2
$2.53M Buy
15,365
+69
+0.5% +$11.4K 1.32% 21
2021
Q1
$2.51M Buy
15,296
+36
+0.2% +$5.83K 1.4% 18
2020
Q4
$2.4M Sell
15,260
-164
-1% -$24.2K 1.42% 19
2020
Q3
$2.3M Buy
15,424
+675
+5% +$99.9K 1.53% 18
2020
Q2
$2.07M Sell
14,749
-60
-0.4% -$8.74K 1.49% 17
2020
Q1
$1.94M Buy
14,809
+1,307
+10% +$185K 1.68% 12
2019
Q4
$1.97M Buy
13,502
+9
+0.1% +$1.22K 1.23% 21
2019
Q3
$1.75M Buy
13,493
+150
+1% +$19.8K 1.17% 22
2019
Q2
$1.86M Sell
13,343
-25
-0.2% -$3.46K 1.22% 19
2019
Q1
$1.87M Sell
13,368
-108
-0.8% -$14.5K 1.3% 17
2018
Q4
$1.74M Hold
13,476
1.4% 16
2018
Q3
$1.86M Sell
13,476
-20
-0.1% -$2.66K 1.23% 16
2018
Q2
$1.64M Hold
13,496
1.13% 18
2018
Q1
$1.73M Sell
13,496
-637
-5% -$86.1K 1.24% 15
2017
Q4
$1.98M Hold
14,133
1.4% 14
2017
Q3
$1.84M Hold
14,133
1.36% 16
2017
Q2
$1.87M Hold
14,133
1.41% 16
2017
Q1
$1.76M Sell
14,133
-25
-0.2% -$2.99K 1.3% 18
2016
Q4
$1.63M Hold
14,158
1.23% 16
2016
Q3
$1.67M Sell
14,158
-100
-0.7% -$12.1K 1.33% 14
2016
Q2
$1.73M Buy
14,258
+200
+1% +$22.7K 1.42% 12
2016
Q1
$1.52M Hold
14,058
1.39% 15
2015
Q4
$1.44M Hold
14,058
1.44% 16
2015
Q3
$1.31M Sell
14,058
-54
-0.4% -$5.22K 1.28% 17
2015
Q2
$1.38M Hold
14,112
1.15% 17
2015
Q1
$1.42M Sell
14,112
-136
-1% -$13.8K 1.14% 17
2014
Q4
$1.49M Buy
14,248
+198
+1% +$20.9K 1.25% 20
2014
Q3
$1.5M Sell
14,050
-7,740
-36% -$803K 1.25% 19
2014
Q2
$2.28M Buy
21,790
+70
+0.3% +$7.08K 1.39% 17
2014
Q1
$2.13M Buy
21,720
+147
+0.7% +$13.6K 1.36% 19
2013
Q4
$1.98M Buy
21,573
+70
+0.3% +$6.45K 1.32% 20
2013
Q3
$1.86M Sell
21,503
-30
-0.1% -$2.69K 1.32% 18
2013
Q2
$1.85M Buy
+21,533
New +$1.83M 1.26% 19

Other funds holding JNJ

Aspen Investment Management's JNJ Position: Q2 2026 in Review

Aspen Investment Management increased its Johnson & Johnson (JNJ) stake by 1.7% in Q2 2026, buying an estimated $70.4K and bringing the position to 18,458 shares worth $4.69M. The position accounts for 1.26% of the portfolio, ranked #18.

Aspen Investment Management first reported a position in JNJ in Q2 2013 and has held it in 53 quarters since. 1,657 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Aspen Investment Management held 18,458 shares of Johnson & Johnson worth $4.69M as of Q2 2026.
  • Aspen Investment Management bought 302 Johnson & Johnson shares in Q2 2026, an estimated $70.4K.
  • Johnson & Johnson made up 1.26% of Aspen Investment Management's portfolio in Q2 2026, its #18 holding.
  • Aspen Investment Management first reported a position in Johnson & Johnson in Q2 2013 and has held it in 53 quarters since.
  • 1,657 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Aspen Investment Management's 13F filing for Q2 2026, filed 17 Jul 2026.